Highlights & Basics
- Rabies is a notifiable disease in the US.
- Preventable through prompt medical care. Postexposure prophylaxis with wound cleansing, immunization, and rabies immune globulin is highly effective at preventing the disease when given promptly and properly.
- Symptoms begin with a nonspecific prodromal illness. In encephalitic rabies, this is followed by early-onset behavioral changes and late-onset paralysis. In the paralytic form, the behavioral changes are absent.
- Almost always fatal following onset of clinical signs. The disease is rapidly progressive, leading to death within 2 weeks in most cases. Some survivors have been reported.
- Pre-exposure prophylaxis is recommended for certain people at high risk for exposure.
Quick Reference
History & Exam
Key Factors
Other Factors
Diagnostics Tests
Treatment Options
Definition
Epidemiology
Etiology
Pathophysiology
Images
A canine suspected of being rabid that had been exhibiting signs of restlessness and overall uncharacteristic aggressive behavior
Illustration of rabies virus in longitudinal section
Illustration of rabies virus in cross-section. Concentric layers: envelope membrane bilayer, M protein, and tightly coiled encased RNA
This transmission electron micrograph reveals the presence of Lagos bat virus virions and an intracytoplasmic inclusion body in this tissue sample
Citations
World Health Organization. Weekly epidemiological record. Rabies vaccines: WHO position paper. April 2018 [internet publication].[Full Text]
Centers for Disease Control and Prevention. Use of a modified preexposure prophylaxis vaccination schedule to prevent human rabies: recommendations of the Advisory Committee on Immunization Practices - United States, 2022. May 2022 [internet publication].[Full Text]
World Health Organization. WHO expert consultation on rabies: WHO TRS N°1012 (third report). April 2018 [internet publication].[Full Text]
Rupprecht CE, Briggs D, Brown CM, et al; Centers for Disease Control and Prevention. Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep. 2010;59:1-9.[Abstract][Full Text]
Willoughby RE Jr, Tieves KS, Hoffman GM, et al. Survival after treatment of rabies with induction of coma. N Engl J Med. 2005;352:2508-2514.[Abstract][Full Text]
1. World Health Organization. Zero by 30: the global strategic plan to end human deaths from dog-mediated rabies by 2030. June 2018 [internet publication].[Full Text]
2. Rawat AK, Rao SK. Survival of a rabies patient. Indian Pediatr. 2011;48:574.[Abstract]
3. Centers for Disease Control and Prevention. Presumptive abortive human rabies - Texas, 2009. MMWR Morb Mortal Wkly Rep. 2010;59:185-190.[Abstract][Full Text]
4. Karahocagil MK, Akdeniz H, Aylan O, et al. Complete recovery from clinical rabies: case report. Turkiye Klinikleri J Med Sci. 2013;33:547-552.[Full Text]
5. Hampson K, Coudeville L, Lembo T, et al. Estimating the global burden of endemic canine rabies. PLoS Negl Trop Dis. 2015;9:e0003709.[Abstract][Full Text]
6. Rupprecht CE, Gibbons RV. Clinical practice: prophylaxis against rabies. N Engl J Med. 2004;351:2626-2635.[Abstract]
7. Centers for Disease Control and Prevention. Human rabies. Sep 2021 [internet publication].[Full Text]
8. Pieracci EG, Pearson CM, Wallace RM, et al. Vital signs: trends in human rabies deaths and exposures - United States, 1938-2018. MMWR Morb Mortal Wkly Rep. 2019 Jun 14;68(23):524-8.[Abstract][Full Text]
9. Centers for Disease and Control and Prevention. Notes from the field: three human rabies deaths attributed to bat exposures -- United States, August 2021. Jan 2022 [internet publication].[Full Text]
10. Blackburn D, Minhaj FS, Al Hammoud R, et al. Human rabies -- Texas, 2021. MMWR Morb Mortal Wkly Rep 2022;71:1547-49.[Full Text]
11. Pan American Health Organisation. Rabies persists in only four countries of Latin America and the Caribbean. 21 September 2018 [internet publication].[Full Text]
12. Rotivel Y, Goudal M, Wirth S, et al. Rabies is a risk for travelling children [in French]. Arch Pediatr. 1998;5:561-567.[Abstract]
13. Noah DL, Drenzek CL, Smith JS, et al. Epidemiology of human rabies in the United States, 1980 to 1996. Ann Intern Med. 1998;128:922-930.[Abstract]
14. Blanton JD, Palmer D, Dyer J, et al. Rabies surveillance in the United States during 2010. J Am Vet Med Assoc. 2011;239:773-783.[Abstract][Full Text]
15. Messenger SL, Smith JS, Rupprecht CE. Emerging epidemiology of bat-associated cryptic cases of rabies in humans in the United States. Clin Infect Dis. 2002;35:738-747.[Abstract][Full Text]
16. Velasco-Villa A, Reeder SA, Orciari LA, et al. Enzootic rabies elimination from dogs and reemergence in wild terrestrial carnivores, United States. Emerg Infect Dis. 2008;14:1849-1854.[Abstract]
17. World Health Organization. Rabies. Jan 2023 [internet publication].[Full Text]
18. Gunawardena PS, Marston DA, Ellis RJ, et al. Lyssavirus in Indian Flying Foxes, Sri Lanka. Emerg Infect Dis. 2016 Aug;22(8):1456-9.[Abstract][Full Text]
19. Aréchiga Ceballos N, Vázquez Morón S, Berciano JM, et al. Novel lyssavirus in bat, Spain. Emerg Infect Dis. 2013 May;19(5):793-5.[Abstract][Full Text]
20. Hu SC, Hsu CL, Lee MS, et al. Lyssavirus in Japanese Pipistrelle, Taiwan. Emerg Infect Dis. 2018 Apr;24(4):782-785.[Abstract][Full Text]
21. Vora NM, Basavaraju SV, Feldman KA, et al; Transplant-Associated Rabies Virus Transmission Investigation Team. Raccoon rabies virus variant transmission through solid organ transplantation. JAMA. 2013;310:398-407.[Abstract]
22. Monroe BP, Yager P, Blanton J, et al. Rabies surveillance in the United States during 2014. J Am Vet Med Assoc. 2016;248:777-788.[Abstract][Full Text]
23. Zhou H, Zhu W, Zeng J, et al. Probable rabies virus transmission through organ transplantation, China, 2015. Emerg Infect Dis. 2016;22:1348-1352.[Abstract][Full Text]
24. Saeed B, Al-Mousawi M. Rabies acquired through kidney transplantation in a child: a case report. Exp Clin Transplant. 2017;15:355-357.[Abstract][Full Text]
25. Centers for Disease Control and Prevention. Translocation of an anteater (tamandua tetradactyla) infected with rabies from Virginia to Tennessee resulting in multiple human exposures, 2021. Apr 2022 [internet publication].[Full Text]
26. Lafon M. Rabies virus receptors. J Neurovirol. 2005;11:82-87.[Abstract]
27. Jackson AC. Diabolical effects of rabies encephalitis. J Neurovirol. 2016;22:8-13.[Abstract]
28. Rossiter JP, Hsu L, Jackson AC. Selective vulnerability of dorsal root ganglia neurons in experimental rabies after peripheral inoculation of CVS-11 in adult mice. Acta Neuropathol. 2009;118:249-259.[Abstract]
29. Hemachudha T, Wacharapluesadee S, Mitrabhakdi E, et al. Pathophysiology of human paralytic rabies. J Neurovirol. 2005;11:93-100.[Abstract]
30. Hemachudha T, Ugolini G, Wacharapluesadee S, et al. Human rabies: neuropathogenesis, diagnosis, and management. Lancet Neurol. 2013;12:498-513.[Abstract]
31. Gibbons RV. Cryptogenic rabies, bats, and the question of aerosol transmission. Ann Emerg Med. 2002;39:528-536.[Abstract]
32. Centers for Disease Control and Prevention. CDC Yellow Book 2024: health information for international travel. Section 5: travel-associated infections & diseases - rabies. May 2023 [internet publication].[Full Text]
33. World Health Organization. Weekly epidemiological record. Rabies vaccines: WHO position paper. April 2018 [internet publication].[Full Text]
34. Centers for Disease Control and Prevention. Use of a modified preexposure prophylaxis vaccination schedule to prevent human rabies: recommendations of the Advisory Committee on Immunization Practices - United States, 2022. May 2022 [internet publication].[Full Text]
35. Kessels JA, Recuenco S, Navarro-Vela AM, et al. Pre-exposure rabies prophylaxis: a systematic review. Bull World Health Organ. 2017;95:210C-219C.[Abstract][Full Text]
36. Anderson LJ, Nicholson KG, Tauxe RV, et al. Human rabies in the United States, 1960 to 1979: epidemiology, diagnosis, and prevention. Ann Intern Med. 1984;100:728-735.[Abstract]
37. Soun VV, Eidson M, Trimarchi CV, et al. Antemortem diagnosis of New York human rabies case and review of U.S. cases. Int J Biomed Sci. 2006;2:433-444.
38. Hemachudha T, Laothmatas J, Rupprecht CE. Human rabies: a disease of complex neuropathogenetic mechanisms and diagnostic challenges. Lancet. 2002;2:101-109.[Abstract]
39. World Health Organization. WHO expert consultation on rabies: WHO TRS N°1012 (third report). April 2018 [internet publication].[Full Text]
40. Laothamatas J, Hemachudha T, Mitrabhakdi E, et al. MR imaging in human rabies. AJNR Am J Neuroradiol. 2003;24:1102-1109.[Abstract][Full Text]
41. Gable MS, Sheriff H, Dalmau J, et al. The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project. Clin Infect Dis. 2012;54:899-904.[Abstract]
42. Hantson P, Guerit JM, de Tourtchaninoff M, et al. Rabies encephalitis mimicking the electrophysiological pattern of brain death. Eur Neurol. 1993;33:212-217.[Abstract]
43. Centers for Disease Control and Prevention. Rabies, human: 2011 case definition. 2011 [internet publication].[Full Text]
44. Rupprecht CE, Briggs D, Brown CM, et al; Centers for Disease Control and Prevention. Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep. 2010;59:1-9.[Abstract][Full Text]
45. Willoughby RE Jr, Opladen T, Maier T, et al. Tetrahydrobiopterin deficiency in human rabies. J Inherit Metab Dis. 2008;32:65-68.[Abstract]
46. Marsden SC, Cabanban CR. Rabies: a significant palliative care issue. Prog Palliat Care. 2006;14:62-67.
47. Jackson AC, Warrell MJ, Rupprecht CE, et al. Management of rabies in humans. Clin Infect Dis. 2003;36:60-63.[Abstract]
48. Medical College of Wisconsin. Milwaukee rabies protocol, version 6. Nov 2018[internet publication].[Full Text]
49. Willoughby RE Jr, Tieves KS, Hoffman GM, et al. Survival after treatment of rabies with induction of coma. N Engl J Med. 2005;352:2508-2514.[Abstract][Full Text]
50. Willoughby RE, Roy-Burman A, Martin KW, et al. Generalized cranial artery spasm in human rabies. Dev Biol (Basel). 2008;131:367-375.[Abstract]
51. World Health Organization. Rabies monoclonal antibodies post exposure prophylaxis. December 2016 [internet publication].[Full Text]
52. Gogtay NJ, Munshi R, Ashwath Narayana DH, et al. Comparison of a novel human rabies monoclonal antibody to human rabies immunoglobulin for postexposure prophylaxis: a phase 2/3, randomized, single-blind, noninferiority, controlled study. Clin Infect Dis. 2018 Jan 18;66(3):387-395. [Abstract]
53. Yamada K, Noguchi K, Komeno T, et al. Efficacy of favipiravir (T-705) in rabies postexposure prophylaxis. J Infect Dis. 2016;213:1253-1261.[Abstract][Full Text]
54. Bussereau F, Picard M, Blancou J, et al. Treatment of rabies in mice and foxes with antiviral compounds. Acta Virol. 1988;32:33-49.[Abstract]
55. Kalimuddin S, Wijaya L, Chan YFZ, et al. A phase II randomized study to determine the safety and immunogenicity of the novel PIKA rabies vaccine containing the PIKA adjuvant using an accelerated regimen. Vaccine. 2017 Nov 22;35(51):7127-32.[Abstract][Full Text]
56. Brown CM, Slavinski S, Ettestad P, et al; National Association of State Public Health Veterinarians; Compendium of Animal Rabies Prevention and Control Committee. Compendium of animal rabies prevention and control, 2016. J Am Vet Med Assoc. 2016;248:505-517.[Abstract][Full Text]
57. Mani RS, Anand AM, Madhusudana SN. Human rabies in India: an audit from a rabies diagnostic laboratory. Trop Med Int Health. 2016 Apr;21(4):556-63.[Abstract][Full Text]
58. Whitehouse ER, Mandra A, Bonwitt J, et al. Human rabies despite post-exposure prophylaxis: a systematic review of fatal breakthrough infections after zoonotic exposures. Lancet Infect Dis. 2023 May;23(5):e167-74.[Abstract]
Key Articles
Other Online Resources
Referenced Articles
Sign in to access our clinical decision support tools